Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chondrus crispus, commonly known as Irish moss, is a species of red macroalgae (Rhodophyta) found along the rocky Atlantic coasts. It is a primary source of carrageenan, a sulfated polysaccharide widely utilized in the food and pharmaceutical industries as a gelling agent, thickener, and stabilizer. Beyond its industrial applications, Chondrus crispus is investigated for its nutritional and therapeutic potential, including prebiotic effects on human gut microbiota, antioxidant and antibacterial activities, and its role in promoting satiety and managing food intake. In veterinary science, it has been studied for its ability to reduce enteric methane emissions in ruminants. The seaweed also serves as a source for bioactive compounds such as antimicrobial peptides and novel enzymes like flavonoid sulfotransferases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chondrus crispus.